Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
Recruiting now · Phase 3
Conditions studied: Extensive Stage Small Cell Lung Cancer (ES-SCLC)
In brief
The goal of this clinical study is to learn more about the study drug sacituzumab govitecan (SG; Trodelvy®; GS-0132; IMMU 132), versus standard of care (SOC) in participants with previously treated extensive stage small cell lung cancer (ES-SCLC). The primary objectives of this study are to compare the effect of SG to SOC on overall survival (OS).
Key facts
- Study ID
- NCT06801834
- Run by
- Gilead Sciences
- People needed
- 695
- Starts
- 2025-04-04
- Expected to finish
- 2029-10-01
- Last updated by the study team
- 2026-07-16
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Genesis Cancer and Blood Institute — Hot Springs, Arkansas, United States (enrolling)
- Centro Médico San Roque — San Miguel de Tucumán, Argentina (enrolling)
- Hope and Healing Cancer Services — Hinsdale, Illinois, United States (enrolling)
- Los Angeles Cancer Network — Anaheim, California, United States (enrolling)
- Boca Raton Regional — Miami, Florida, United States (enrolling)
- Parkview Research Center — Fort Wayne, Indiana, United States (enrolling)
- IU Health Ball Memorial Hospital and Physicians - Cancer Center - Muncie — Muncie, Indiana, United States (enrolling)
- Northwest Cancer Centers — Dyer, Kentucky, United States (enrolling)
- St. Claire Regional Medical Ce — Morehead, Kentucky, United States (enrolling)
- Southern Illinois University School of Medicine — Springfield, Illinois, United States (enrolling)
- Springfield Clinic — Springfield, Illinois, United States (enrolling)
- New Mexico Oncology Hematology Consultants, Ltd — Albuquerque, New Mexico, United States (enrolling)
- University Hospitals Seidman Cancer Center — Sandusky, Ohio, United States (enrolling)
- Taylor Cancer Research Foundation — Toledo, Ohio, United States (enrolling)
- Spoknwrd Clinical Trials Inc. — Easton, Pennsylvania, United States (enrolling)
- Hendrick Health System — Abilene, Texas, United States (enrolling)
- MD Anderson Cancer Center — Houston, Texas, United States (enrolling)
- Texas Oncology - San Antonio — New Braunfels, Texas, United States (enrolling)
- The University of Texas Health Science Center at Tyler — Tyler, Texas, United States (enrolling)
- Gundersen Health System — West Salem, Wisconsin, United States (enrolling)
- Hospital Britanico de Buenos Aires — Buenos Aires, Argentina (enrolling)
- Universidad de Buenos Aires - Facultad de Medicina - Instituto Alexander Fleming (Buenos Aires) — Buenos Aires, Argentina (enrolling)
- Clinica Colon S.A.A (Clinica y Maternidad Colon) Investigaciones Clinicas de Mar del Plata — Buenos Aires, Argentina (enrolling)
- Centro Oncologico de Excelencia (San Juan) — San Juan, Argentina (enrolling)
- Sanatorio Parque SA — Santa Fe, Argentina (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.